Patterns of treatment and costs of intermediate and advanced hepatocellular carcinoma management in four Italian centers

References

• El-SeragHBHepatocellular carcinoma: an epidemiologic viewJ Clin Gastroenterol2002355 Suppl 2S72S7812394209
   PubMed Web of Science ®Google Scholar
• CabibboGEneaMAttanasioMBruixJCraxìACammàCA meta-analysis of survival rates of untreated patients in randomized clinical trials of hepatocellular carcinomaHepatology2010511274128320112254
   PubMed Web of Science ®Google Scholar
• VillaECritelliRLeiBMarzocchiGNeoangiogenesis-related genes are hallmarks of fast-growing hepatocellular carcinomas and worst survival. Results from a prospective studyGut Epub29201510.1136/gutjnl-2014-308483.
   PubMed Web of Science ®Google Scholar
• International Agency for Research on CancerWorld Health OrganizationGLOBOCAN 2012: estimated cancer incidence, mortality and prevalence worldwide Available from: http://globocan.iarc.fr/Pages/fact_sheets_cancer.aspxAccessed January 29, 2015
   Google Scholar
• EverhartJERuhlCEBurden of digestive diseases in the United States part II: lower gastrointestinal diseasesGastroenterology2009136374175419166855
   PubMed Web of Science ®Google Scholar
• FerlayJShinHRBrayFFormanDMathersCParkinDMEstimates of worldwide burden of cancer in 2008: GLOBOCAN 2008Int J Cancer2010127122893291721351269
   PubMed Web of Science ®Google Scholar
• El-SeragHBMasonACRising incidence of hepatocellular carcinoma in the United StatesN Engl J Med199934074575010072408
   PubMed Web of Science ®Google Scholar
• I numeri del cancro in Italia 2014. AIOM AIRTUM. [Cancer numbers in Italy in 2014. AIOM AIRTUM] Available from: http://www.registri-tumori.it/PDF/AIOM2014/I_numeri_del_cancro_2014.pdfAccessed January 21, 2015 Italian
   Google Scholar
• SchwartzMRoayaieSKonstadoulakisMStrategies for the management of hepatocellular carcinomaNat Clin Pract Oncol20074742443217597707
   PubMedGoogle Scholar
• YangJDRobertsLRHepatocellular carcinoma: a global viewNat Rev Gastroenterol Hepatol20107844845820628345
   PubMed Web of Science ®Google Scholar
• KudoMIzumiNKokudoNManagement of hepatocellular carcinoma in Japan: consensus-based clinical practice guidelines proposed by the Japan Society of Hepatology (JSH) 2010 updated versionDig Dis20112933936421829027
   PubMed Web of Science ®Google Scholar
• American Cancer SocietyLiver Cancer Available from: http://www.cancer.org/cancer/livercancer/detailedguide/liver-cancer-risk-factorsAccessed February 3, 2015
   Google Scholar
• LlovetJMBrúCBruixJPrognosis of hepatocellular carcinoma: the BCLC staging classificationSemin Liver Dis19991932933810518312
   PubMed Web of Science ®Google Scholar
• BruixJShermanMAASLD Practice Guideline 2010. Management of hepatocellular carcinoma: an updateHepatology2011531020102221374666
   PubMedGoogle Scholar
• European Association for the Study of the LiverEuropean Organisation for Research and Treatment of CancerEASL–EORTC clinical practice guidelines: management of hepatocellular carcinomaJ Hepatol20125690894322424438
   PubMed Web of Science ®Google Scholar
• Italian Association for the Study of the Liver (AISF)AISF Expert PanelAISF Coordinating CommitteeBolondiLCilloUColomboMPosition paper of the Italian Association for the Study of the Liver (AISF): the multidisciplinary clinical approach to hepatocellular carcinomaDig Liver Dis201345971272310.1016/j.dld.2013.01.01223769756
   PubMedGoogle Scholar
• LlovetJMBruixJSystematic review of randomized trials for unresectable hepatocellular carcinoma: chemoembolization improves survivalHepatology20033742944212540794
   PubMed Web of Science ®Google Scholar
• LlovetJMBruixJMolecular targeted therapies in hepatocellular carcinomaHepatology2008481312132718821591
   PubMed Web of Science ®Google Scholar
• CammàCSchepisFOrlandoATransarterial chemoembolization for unresectable hepatocellular carcinoma: meta-analysis of randomized controlled trialsRadiology2002224475412091661
   PubMed Web of Science ®Google Scholar
• CabibboGGencoCDi MarcoVPredicting survival in patients with hepatocellular carcinoma treated by transarterial chemoembolisationAliment Pharmacol Ther20113419620421564144
   PubMed Web of Science ®Google Scholar
• LlovetJMBustamanteJCastellsANatural history of untreated nonsurgical hepatocellular carcinoma: rationale for the design and evaluation of therapeutic trialsHepatology19992962679862851
   PubMed Web of Science ®Google Scholar
• BolondiLCraxiATrevisaniFRefining sorafenib therapy: lessons from clinical practiceFuture Oncol201511344946525360997
   PubMed Web of Science ®Google Scholar
• LlovetJMRicciSMazzaferroVSorafenib in advanced hepatocellular carcinomaN Engl J Med2008359437839010.1056/NEJMoa070885718650514
   PubMed Web of Science ®Google Scholar
• ChengALKangYKChenZEfficacy and safety of sorafenib in patients in the Asia-Pacific region with advanced hepatocellular carcinoma: a phase III randomised, double-blind, placebo-controlled trialLancet Oncol2009101253410.1016/S1470-2045(08)70285-719095497
   PubMed Web of Science ®Google Scholar
• AIOM Guidelines2014 Available from: http://www.aiom.itAccessed February 24, 2015
   Google Scholar
• TheinHHIsaranuwatchaiWCampitelliMAHealth care costs associated with hepatocellular carcinoma: a population-based studyHepatology20135841375138410.1002/hep.2623123300063
   PubMed Web of Science ®Google Scholar
• MishraAOtgonsurenMVenkatesanCThe inpatient economic and mortality impact of hepatocellular carcinoma from 2005 to 2009: analysis of the US nationwide inpatient sampleLiver Int20133381281128610.1111/liv.1220123710596
   PubMed Web of Science ®Google Scholar
• ZhuLLiJDongXHospital costs and length of hospital stay for hepatectomy in patients with hepatocellular carcinoma: results of a prospective case seriesHepatogastroenterology2011581122052205710.5754/hge1014922234077
   PubMedGoogle Scholar
• GondekKLangKDanchenkoNEconomic costs of hepatocellular carcinoma in the United StatesJ Clin Oncol200826Suppl 156555 ASCO Annual Meeting Proceedings (Post-Meeting Edition)
   Google Scholar
• LangHCWuJCYenSHThe lifetime cost of hepatocellular carcinomaAppl Health Econ Health Policy200861556518774870
   PubMedGoogle Scholar
• MarinhoRTGiriaJMouraMGRising costs and hospital admissions for hepatocellular carcinoma in Portugal (1993–2005)World J Gastroenterol200713101522152717461443
   PubMed Web of Science ®Google Scholar
• IavaroneMCabibboGPiscagliaFon behalf of the SOFIA (SOraFenib Italian Assessment) study groupField-practice study of sorafenib therapy for hepatocellular carcinoma: a prospective multi-center study in ItalyHepatology2011542055206321898496
   PubMed Web of Science ®Google Scholar
• CammáCCabibboGPettaSon behalf of the WEF and the SOFIA study groupsCost-effectiveness of sorafenib treatment in field practice for patients with hepatocellular carcinomaHepatology2013571046105423299720
   PubMed Web of Science ®Google Scholar
• SpoelstraSLGivenCWAssessment and measurement of adherence to oral antineoplastic agentsSemin Oncol Nurs201127211613221514481
   PubMedGoogle Scholar
• Determinazione AIFA del 3 luglio 2006, Gazzetta Ufficiale n. 156 del 7 luglio 2006. [AIFA Determination of 3 July 2006. Official Gazette no 156 of 7 July 2006] Available from: http://www.medicoeleggi.com/argomenti00/italia2006/19145.htmAccessed January 28, 2015 Italian
   Google Scholar
• Determinazione AIFA del 27 settembre 2006, Gazzetta n. 227 del 29 settembre 2006. [AIFA Determination 26 September 2006. Official Gazette no 156 of 29 September 2006] Available from: http://www.medicoeleggi.com/argomenti00/italia2006/19186.htmAccessed January 28, 2015 Italian
   Google Scholar
• CabibboGMaidaMCammàCCraxìAIs the efficacy of sorafenib treatment in patients with hepatocellular carcinoma affected by age?Expert Rev Anticancer Ther201313121355136124224926
   PubMed Web of Science ®Google Scholar
• DECRETO 18 ottobre 2012. Remunerazione prestazioni di assistenza ospedaliera per acuti, assistenza ospedaliera di riabilitazione e di lungodegenza post acuzie e di assistenza specialistica ambulatoriale. (13A00528) (GU Serie Generale n. 23 del 28-1-2013 – Suppl Ordinario n.8. [Decree 18 October 2012. Remuneration performance of hospital assistance for acutes, hospital assistance to rehabilitation and long-term assistance after acute and specialist outpatient assistance] Available from: http://www.gazzettaufficiale.it/eli/id/2013/01/28/13A00528/sgAccessed January 29, 2015 Italian
   Google Scholar
• ZhangZMGuoJXZhangZCTherapeutic options for intermediate-advanced hepatocellular carcinomaWorld J Gastroenterol201117131685168921483627
   PubMed Web of Science ®Google Scholar
• Conferenza Stato-Regioni 21/11/2014 – Rapporto STEM: “Prima analisi dei costi per il personale del Servizio Sanitario Nazionale Anni 2010/2012” [State-Regions Conference 11/21/14. STEM Report: “First cost analysis for National Health Service personnel in 2010/2012”] Available from: http://www.regioni.it/riforme/2014/11/21/conferenza-stato-regioni-21112014-rapporto-stem-prima-analisi-dei-costi-per-il-personale-del-servizio-sanitario-nazionale-anni-20102012-376317/Accessed January 23, 2015 Italian
   Google Scholar
• Italian Medicines AgencyReimbursement list. Class H list Available from: http://www.agenziafarmaco.gov.it/sites/default/files/111.84470.1172743348645ce4c.pdfAccessed January 23, 2015
   Google Scholar
• SetacciFde DonatoGChisciEEconomic impact of endarterectomy vs carotid artery stenting: a one year, single center studyEuroIntervention20073334034419737715
   PubMedGoogle Scholar